Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 31, 2025 08:30 ET | Source: Interpace Biosciences, Inc.

Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2024 Financial and Business Results

●Q4 and FY Test volume increase 21% and 17% year-over-year ●Q4 and FY Volume, Revenue, and Profitability at all-time record levels PARSIPPANY, NJ, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Interpace...
August 09, 2023 12:30 ET | Source: Interpace Biosciences, Inc.

Interpace Biosciences Announces Record Second Quarter 2023 Financial and Business Results

●Q2 Revenue of $11.0 million; a 49% increase year-over-year; highest quarter in history ●Q2 Test volume up 15% year over year to record levels ●Q2 Reimbursement improvement up 34% year-over-year...
June 05, 2023 16:05 ET | Source: Interpace Biosciences, Inc.

Interpace Expects to Stop Offering PancraGEN® Test Due to CMS Decision to End Reimbursement as of July 17, 2023

PARSIPPANY, NJ, June 05, 2023 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced that the Centers for Medicare & Medicaid Services (CMS)...